Medical News

---

• Ingested L-arginine does not significantly affect FENO levels in children
• Trauma of war increases asthma risk
• Airways obstruction main cause of lung function decline in 9/11 workers
• Quitting smoking would cut CV risk in schizophrenia patients
• Factors linked to service disengagement among FEP patients uncovered
• Ticagrelor effective in nonresponders to clopidogrel treatment
• Measuring BP variability could improve stroke risk prediction
• Early results suggest trastuzumab may improve radiotherapy efficacy
• IMRT versus RapidArc – superiority depends on PTV
• External sphincter temperature predicts voiding function after cryoablation
• Asian women less likely than whites to conceive with IVF
• All vaginal progesterone regimens are equal
• IVF outcomes comparable in PCOS and PCO-only women
• Sperm functional impairments detected in SCI infertility
• Mediterranean diet ‘improves IVF/ICSI outcomes’
• Severe hypertriglyceridemia linked with excess CHD, stroke mortality
• Eprotirome helps reduce lipids in statin-treated patients
• ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins
• INVEST analysis challenges diabetic BP targets
• ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk
• Valsartan and nateglinide disappoint in diabetes prevention
• INVEST analysis challenges diabetic BP targets
• ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk
• ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins
• Valsartan and nateglinide disappoint in diabetes prevention
• Percutaneous MitraClip device ‘good option’ for mitral regurgitation
• INVEST analysis challenges diabetic BP targets
• ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk
• ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins

Ingested L-arginine does not significantly affect FENO levels in children Posted: 15 Mar 2010 05:00 PM PDT Results from a UK study show that ingested L-arginine has no clinically significant affect on Fractional exhaled nitric oxide levels in children.

Trauma of war increases asthma risk Posted: 15 Mar 2010 05:00 PM PDT Civilians in war zones who have been traumatized by their experiences are at an increased risk for developing asthma, researchers have found.

Airways obstruction main cause of lung function decline in 9/11 workers Posted: 15 Mar 2010 05:00 PM PDT Airways obstruction is the main feature underlying lung function reductions in rescue workers who attended the aftermath of the terrorist attacks on World Trade Center on 11 September, 2001, US research shows.

Quitting smoking would cut CV risk in schizophrenia patients Posted: 15 Mar 2010 05:00 PM PDT Schizophrenia patients are significantly more likely to smoke than the general population, and would have around a 90% reduction in their 10-year cardiovascular event risk if they quit, the results of a Spanish study indicate.

Factors linked to service disengagement among FEP patients uncovered Posted: 15 Mar 2010 05:00 PM PDT Attention should be paid to service disengagement, alongside strategies to increase engagement, in the treatment of first-episode psychosis, say international researchers who also cite family involvement as a key factor.

Ticagrelor effective in nonresponders to clopidogrel treatment Posted: 14 Mar 2010 05:00 PM PDT Coronary artery disease patients who are unresponsive to clopidogrel therapy can reduce their platelet reactivity using ticagrelor, show study findings published in the journal Circulation.

Measuring BP variability could improve stroke risk prediction Posted: 14 Mar 2010 05:00 PM PDT Visit-to-visit variability in blood pressure is a powerful predictor of people's stroke risk, and may help to guide antihypertensive prescribing, shows research.

Early results suggest trastuzumab may improve radiotherapy efficacy Posted: 14 Mar 2010 05:00 PM PDT A small trial of women with locally advanced breast cancer has revealed that trastuzumab may improve the efficacy of radiotherapy without increasing operative morbidity or radiotherapy-related toxicity.

IMRT versus RapidArc – superiority depends on PTV Posted: 14 Mar 2010 05:00 PM PDT For men undergoing radiotherapy of the prostate, conventional intensity-modulated radiotherapy performs better than RapidArc in dose sparing of the bladder, rectum, and small bowel for planning target volumes that include the prostate, seminal vesicles, and lymph nodes, researchers report.

External sphincter temperature predicts voiding function after cryoablation Posted: 14 Mar 2010 05:00 PM PDT Patients who have an external sphincter temperature of 23°C or less during cryoablation are significantly more likely to experience urgency and/or frequency of urinary retention after cryoablation, study findings show.

Asian women less likely than whites to conceive with IVF Posted: 14 Mar 2010 05:00 PM PDT Asian women have worse outcomes with IVF than white women, study findings indicate.

All vaginal progesterone regimens are equal Posted: 14 Mar 2010 05:00 PM PDT Vaginal progesterone gel is equivalent to other vaginal progesterone formulations with regard to clinical pregnancy rates in women undergoing assisted reproduction, a meta-analysis has found

IVF outcomes comparable in PCOS and PCO-only women Posted: 14 Mar 2010 05:00 PM PDT IVF outcomes are similar in women with polycystic ovary syndrome and those with the isolated sonographic finding of polycystic ovary, research suggests.

Sperm functional impairments detected in SCI infertility Posted: 14 Mar 2010 05:00 PM PDT Sperm from men with spinal cord injury exhibit reduced hyaluronic acid binding and acrosin activity, study findings show.

Mediterranean diet ‘improves IVF/ICSI outcomes’ Posted: 14 Mar 2010 05:00 PM PDT Eating a predominantly "Mediterranean" diet increases the likelihood of conceiving with assisted reproduction techniques, study findings show.

Severe hypertriglyceridemia linked with excess CHD, stroke mortality Posted: 14 Mar 2010 05:00 PM PDT Severe hypertriglyceridemia is associated with a markedly increased risk for coronary heart disease and stroke mortality, even in the absence of diabetes, a UK study shows.

Eprotirome helps reduce lipids in statin-treated patients Posted: 14 Mar 2010 05:00 PM PDT Treatment with the thyroid hormone analogue eprotirome produces significant additional reductions in low-density lipoprotein cholesterol in statin-treated patients with dyslipidemia, report researchers.

ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins Posted: 14 Mar 2010 05:00 PM PDT Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial.

INVEST analysis challenges diabetic BP targets Posted: 14 Mar 2010 05:00 PM PDT Tight control of systolic blood pressure to a target of less than 130 mmHg in diabetics with coronary artery disease does not significantly reduce the incidence of cardiovascular events compared with usual control, and is associated with increased all-cause mortality, shows an analysis of INVEST.

ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk Posted: 14 Mar 2010 05:00 PM PDT Intensive blood pressure control does not reduce the rate of cardiovascular events in patients with Type 2 diabetes and high CV risk, reveals research presented at the 59th Annual Scientific Sessions of the American College of Cardiology in Atlanta, Georgia, USA.

Valsartan and nateglinide disappoint in diabetes prevention Posted: 14 Mar 2010 05:00 PM PDT Adding treatment with the ACE inhibitor valsartan to lifestyle modification modestly reduces progression to diabetes in patients with impaired glucose tolerance and cardiovascular disease or risk factors, whereas the short-acting insulin secretagogue nateglinide has no significant effect, results of the NAVIGATOR trial reveal.

INVEST analysis challenges diabetic BP targets Posted: 14 Mar 2010 05:00 PM PDT Tight control of systolic blood pressure to a target of less than 130 mmHg in diabetics with coronary artery disease does not significantly reduce the incidence of cardiovascular events compared with usual control, and is associated with increased all-cause mortality, shows an analysis of INVEST.

ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk Posted: 14 Mar 2010 05:00 PM PDT Intensive blood pressure control does not reduce the rate of cardiovascular events in patients with Type 2 diabetes and high CV risk, reveals research presented at the 59th Annual Scientific Sessions of the American College of Cardiology in Atlanta, Georgia, USA.

ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins Posted: 14 Mar 2010 05:00 PM PDT Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial.

Valsartan and nateglinide disappoint in diabetes prevention Posted: 14 Mar 2010 05:00 PM PDT Adding treatment with the ACE inhibitor valsartan to lifestyle modification modestly reduces progression to diabetes in patients with impaired glucose tolerance and cardiovascular disease or risk factors, whereas the short-acting insulin secretagogue nateglinide has no significant effect, results of the NAVIGATOR trial reveal.

Percutaneous MitraClip device ‘good option’ for mitral regurgitation Posted: 14 Mar 2010 05:00 PM PDT Percutaneous mitral valve repair using the MitraClip device is associated with fewer complications and comparable efficacy at 12 months relative to mitral valve surgery in select patients with moderate or severe mitral regurgitation, the EVEREST II investigators report.

INVEST analysis challenges diabetic BP targets Posted: 14 Mar 2010 05:00 PM PDT Tight control of systolic blood pressure to a target of less than 130 mmHg in diabetics with coronary artery disease does not significantly reduce the incidence of cardiovascular events compared with usual control, and is associated with increased all-cause mortality, shows an analysis of INVEST.

ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk Posted: 14 Mar 2010 05:00 PM PDT Intensive blood pressure control does not reduce the rate of cardiovascular events in patients with Type 2 diabetes and high CV risk, reveals research presented at the 59th Annual Scientific Sessions of the American College of Cardiology in Atlanta, Georgia, USA.

ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins Posted: 14 Mar 2010 05:00 PM PDT Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610